AG Frey Announces Millions in Settlement with Suboxone Maker for Alleged Monopoly Tactics

Share

Maine Attorney General Aaron Frey announced yesterday that 42 states, led by Wisconsin Attorney General Josh Kaul, have negotiated a nationwisde $102.5 million settlement with the maker of Suboxone, Indivior Inc.  Suboxone is a drug used to treat opioid use disorder.  Maine will receive approximately $3 million from the settlement.

“Manipulating the market for a life-saving drug needed by vulnerable citizens in order to increase company profits is unconscionable,” said AG Frey.  “We hope that this lawsuit shows drug manufacturers that we are watching and will not tolerate conduct that violates our antitrust laws and shamelessly exploits our consumers.”

In 2016, the States filed a complaint against Indivior Inc, alleging that it used illegal means to switch the Suboxone market from tablets to film while attempting to destroy the market for tablets in order to preserve its drug monopoly.  Trial had been set for September 2023.

The agreement which will be submitted to the court in the Eastern District of Pennsylvania for approval, requires Indivior to pay the states $102.5 million.